Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsWatson

    Watson

    Jump to

    • India is a very important market for Watson: IBM

      Watson, which shot to fame after winning television game show Jeopardy in 2011, is now being used across sectors, including assisting in treatment of cancer.

    • IBM bets on startups to take Watson to the next level

      From assigning employees to projects at large IT firms to playing the role of a doctor -- IBM's cognitive computing platform Watson is doing it all in India.

    • Vijay Mallya deals bring Diageo under Sebi lens

      Years after signing the multi-billion dollar takeover transaction with Mallya, Diageo is facing regulatory troubles on multiple fronts and is also at the loggerheads with the embattled businessman himself despite a USD 75-million sweetheart deal it offered him earlier this year.

    • IBM deploys 1st cognitive computing tech platform in India

      Manipal Hospitals' corporate and teaching facilities will adopt 'Watson for Oncology', trained by MSK, that analyses data to identify evidence-based treatment options.

    • Etihad signs $700m collaboration with tech giant IBM

      The agreement was signed last month that plans for the creation of a new cloud data center in Abu Dhabi, company said in a statement released here. The cloud center, to be developed and operated by IBM, will be one of the most sophisticated technology facilities in the Middle East.

    • Diageo braces for legal battle with Mallya over guarantee

      Diageo says one of Vijay Mallya's company has defaulted on a loan to Standard Chartered Bank. And since this, Diageo gave a conditional back-stop guarantee of USD 135 million for this loan, the company may take a hit if the bank chooses to encash this guarantee

    • 21st century is India's century: IBM chief Virginia Rometty

      With strong GDP growth, expanding base of start ups and growing trend of new technologies like cloud in the country, the 21st century is Indian century, IBM chief Virginia Rometty said.

    • IBM sends supercomputer Watson to college to boost its skills

      Watson, the supercomputer famous for beating the world's top "Jeopardy!" champions, is going to college. IBM said that it will provide a Watson system to Rensselaer Polytechnic Institute...

    • Lupin gets US nod to sell copy of oral contraceptive Lutera

      Pharma major Lupin has received US Food and Drug Administration approval to sell a generic version of Watson Laboratories' Lutera 28 Tablets.

    • IBM makes supercomputer Watson unlearn profane Urban Dictionary slangs

      IBM has had to wash its supercomputer Watsons mouth with some digitally cleansing soap after it picked up profane language from the Urban Dictionary.

    • Alembic Pharma named among co-defendants in Pfizer lawsuit

      Alembic Pharmaceuticals and US-based Breckenridge Pharmaceutical have been named co-defendants in a Para IV lawsuit filed by Pfizer in relation to their abbreviated new drug application (ANDA) to market desvenlafaxine succinate extended-release tablets in 50mg and 100mg strength.

    • Ranbaxy puts past to rest, bright future ahead: Macquarie

      Pharma analyst at Macquarie Research, Abhishek Singhal, spoke to CNBC-TV18 about the key takeaways from the management meet post Ranbaxy’s settlement with the US FDA.

    • Lupin's generic Fortamet launch suffers setback in US

      A US district court in New Jersey has granted motion for a preliminary injunction against Lupin's generic version of anti-diabetes drug Fortamet.

    • Ranbaxy jumps after final nod from USFDA to launch Lipitor

      Ranbaxy’s shares jumped over 10% in morning trade on Thursday after it said it has launched its generic version of Lipitor in the US market having received final approval from US Food and Drugs Administration (FDA).

    • Sun Pharma to enter lucrative oral contraceptive mkt in US

      Sun Pharma is all set to enter the lucrative oral contraceptive market in the US, but the going won’t be easy with the entrenched players like Teva and Watson dominating the market. CNBC-TV18’s Archana Shukla reports Sun will even have to take on its Indian peers like Glenmark and Lupin, who have an early mover advantage.

    • Rethinking Legal Talent After Watson!

      By: Jordan Furlong

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347